Fetal macrosomia: Definition, Prediction, Risk and Prevention.
Descripción del Articulo
Fetal macrosomia has been traditionally defined based on an arbitrary birthweight. However, fetal macrosomia is currently defined as a large for gestational age infant (>90 percentil) because of increased perinatal risk. This prospective investigation performed at San Bartolome's Hospital in...
Autor: | |
---|---|
Formato: | artículo |
Fecha de Publicación: | 2015 |
Institución: | Sociedad Peruana de Obstetricia y Ginecología |
Repositorio: | Revista SPOG - Revista Peruana de Ginecología y Obstetricia |
Lenguaje: | español |
OAI Identifier: | oai:ojs.spog:article/1633 |
Enlace del recurso: | http://www.spog.org.pe/web/revista/index.php/RPGO/article/view/1633 |
Nivel de acceso: | acceso abierto |
Sumario: | Fetal macrosomia has been traditionally defined based on an arbitrary birthweight. However, fetal macrosomia is currently defined as a large for gestational age infant (>90 percentil) because of increased perinatal risk. This prospective investigation performed at San Bartolome's Hospital in Lima, Peru, included 1697 pregnant women from June 1990 to June 1993. 278 pregnant women had large infants (LGA) and 1 336 had normal sized infants. The predictor factors for LGA were: excessive weight gain (70%), male fetal sex (77%), placental width > 4 cm (74%), age over 30 years old (41,7%), obesity (33,5%), previous large infant (27%), fasting blood sugar > 79 mg/cIl (21,6%), 2h post prandial glucose > 110 mg/dl (20,7%), height > 160 cm (20%), familial diabetes (13,7%) and anemia (10, 1 %). The predictable maternal complications were: excessive weight gain, anemia, threatened abortion, placenta prove, polihydramnios, cord twist, arterial hypertensionassociated with premature rupture of membranes, dysfunctianal labor with prolonged second stage because of feto pelvic disproportion and shoulder dystocia. We recomned to avoid and treat obesity before pregnancy, to discover risk factors at antenatal clinic and use caloric restriction, prophylactic insulin and induction of labor before 42 week of gestation in order to avoid fetal macrosomia. |
---|
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).